Skip to main content
. 2003 Jun 23;100(14):8436–8441. doi: 10.1073/pnas.1032925100

Fig. 1.

Fig. 1.

Survival curves of 129/Sv recipients of Socs1-/-, Socs1+/+,or Socs1+/- or control 129/Sv bone marrow transplants (a) and C57BL/6 recipients of Socs1-/-, Socs1+/+, or Socs1+/- bone marrow transplants (b). Note the more protracted survival of C57BL/6 mice compared with that of 129/Sv mice when injected with Socs1-/- marrow cells. n, number of mice surveyed in each group.